Complex NF-kappa B Interactions at the Distal Tumor Necrosis Factor Promoter Region in Human Monocytes*

Irina A. UdalovaDagger §, Julian C. KnightDagger §, Vincent VidalDagger , Sergei A. Nedospasovparallel **Dagger Dagger , and Dominic KwiatkowskiDagger

From the Dagger  Oxford University Department of Paediatrics, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom, the parallel  Engelhardt Institute of Molecular Biology, Russian Academy of Sciences and Belozersky Institute of Physico-Chemical Biology Moscow State University, Moscow, Russia, and the ** Intramural Research Support Program, SAIC Frederick, Frederick, Maryland 21702

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We describe a dense cluster of DNA-protein interactions located 600 nucleotides upstream of the transcriptional start site of the human tumor necrosis factor (TNF) gene. This area was identified as being of potential importance for lipopolysaccharide-inducible TNF expression in the human monocyte cell line Mono Mac 6, based on reporter gene analysis of point mutations at a number of nuclear factor kappa B (NF-kappa B)-like motifs within the human TNF promoter region. The area contains two NF-kappa B sites, which are here shown by DNase I and methylation interference footprinting to flank a novel binding site. UV cross-linking studies reveal that the novel site can also bind NF-kappa B as well as an unknown protein(s) of approximately 40 kDa. We show that these three adjacent kappa B-binding sites differ markedly in their relative affinities for p50/p50, p65/p65, and p65/p50, yet this 39-nucleotide segment of DNA appears capable of binding up to three NF-kappa B heterodimers simultaneously. Reporter gene studies indicate that each element of the cluster contributes to lipopolysaccharide-induced transcriptional activation in Mono Mac 6 cells. These findings suggest that NF-kappa B acts in a complex manner to activate TNF transcription in human monocytes.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

A fundamental problem in infectious disease is to understand the mechanisms by which microbial stimuli such as bacterial lipopolysaccharide (LPS)1 regulate the expression of human inflammatory mediators such as tumor necrosis factor-alpha (TNF). Production of TNF by macrophages and monocytes occurs early in infection and orchestrates much of the subsequent inflammatory response (1). Because excessive production of TNF is responsible for many of the pathological consequences of severe infection, its regulation is critical. This occurs at both the transcriptional and post-transcriptional levels (2), with transcriptional regulation showing specificity for both stimulus and cell type (3). Reporter gene studies of the human TNF promoter using a range of stimuli and cell types have identified a number of regulatory elements upstream of the transcriptional start site, mostly within the proximal 200 base pairs (4-13). However, we still have a poor understanding of the precise regulatory events that are responsible for the rapid induction of high level TNF expression in human monocytes and macrophages during acute bacterial infection.

Much debate has centered on the role of nuclear factor-kappa B (NF-kappa B) in transcriptional activation of the human TNF gene in monocytes. Although there is strong evidence that murine TNF expression is influenced by a number of NF-kappa B binding sites (14-16), the situation in humans is less clear. Several lines of circumstantial evidence suggest that NF-kappa B could play an important role. A number of NF-kappa B-like binding motifs are located between the start of transcription of the TNF gene and the 3' terminus of the lymphotoxin-alpha gene: they are here denoted kappa B1 (-873 to -864 nt), kappa B2 (-627 to -618 nt), kappa B2a (-598 to -589 nt), CK-1 (-213 to -204 nt (17)), and kappa B3 (-98 to -89 nt). It is worth noting that site kappa B2 is 100% conserved between mouse, rabbit, and human TNF promoters (18). Moreover, LPS induces nuclear translocation of NF-kappa B in human monocytes, and LPS-inducible TNF expression is suppressed by specific inhibitors of NF-kappa B mobilization (19, 20). However, studies of the role of NF-kappa B in the transcriptional activation of the human TNF gene have yielded a conflicting picture. Initial gene reporter studies suggested that NF-kappa B binding in the human TNF promoter region is of little functional importance when tested in the murine macrophage cell line P388D1 (5) or when analyzed in other contexts such as phorbol 12-myristate 13-acetate stimulation of U937 (myeloblastoid) cells (4) and K562 (erythroblastoid) cells (21). However, recent studies indicate that site kappa B3 contributes to transcriptional activation of the TNF gene by superantigen (6) and cooperates with an adjacent cAMP-responsive element site to provide an enhancement of TNF transcription in LPS-stimulated human monocyte cell line THP-1 (13).

The present investigation focuses on the role of the other NF-kappa B binding sites, in particular the conserved site kappa B2 and its adjacent site kappa B2a. Several studies have shown that NF-kappa B-specific complexes are formed when site kappa B2a is tested against nuclear extracts from stimulated monocytes and macrophages (13, 20, 22), but there has been doubt about their functional importance. For example, reporter gene studies in human THP-1 cells concluded that the region containing kappa B2 and kappa B2a does not contribute to LPS inducibility, even though NF-kappa B-specific complexes were formed at the site kappa B2a with greater affinity than at the apparently functional site kappa B3 (13). However, a different picture emerged when reporter constructs containing the human TNF promoter region were transiently expressed in the murine macrophage line ANA-1. In this cell line, which resembles mature bone marrow macrophages, LPS inducibility was found to fall 5-10-fold as a result of deleting the region from -656 to -442 nt (22, 23).

These discrepant observations raise the intriguing possibility that the functional activity of the region around kappa B2 and kappa B2a has complex determinants that are specific not only for stimulus and cell type but for the stage of cell differentiation as discussed in Ref. 6. Because the primary concern of the present study is the mechanism of LPS-induced TNF expression in human monocytes, here we have used Mono Mac 6, the human cell line whose surface markers and functional properties most closely resemble those of a mature monocyte (24). In this cell line, we find that mutations in sites kappa B2 and kappa B2a sites have a more profound effect on LPS-inducible reporter gene expression than mutations at other NF-kappa B sites in the TNF promoter region. We further show that sites kappa B2 and kappa B2a flank a novel binding site, such that this 39-nt segment of DNA is capable of binding up to three NF-kappa B heterodimers plus an unknown constitutive factor(s). Each element of this cluster appears to contribute to transcriptional activation of the TNF gene.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Plasmids-- Human TNF promoter sequence (-1173 to +130 nt) derived from -1173-CAT construct (19) was used to generate the wild type TNF promoter construct wt (-1173)-pXP1 in eukaryotic expression vector pXP-1 (ATCC), and corresponding fragments with point mutations at sites kappa B2, kappa B2a and kappa B32 were used to generate the mutant TNF promoter constructs kappa B2-mt-pXP1, kappa B2a-mt-pXP1, and kappa B3-mt-pXP1. A set of site-directed mutations at the xi  site, a mutation at site kappa B1, and +6 and +10 insertions between the sites kappa B2 and xi  were generated by PCR using -1173-CAT construct as a template and oligonucleotides bearing nucleotide substitutions: xi -mt1 (F:agctCCGGGGaTccTTTCACTCCCCG; R:agctCGGGGAGTGAAAggAtCCCCGG); xi -mt2 (F:agctCCGGGGGTGATTTggaTCCCCG; R:agctCGGGGAtccAAACACCCCCGG); xi -mt3 (F:agctCCGGGGGGTGgaTcCACTCCCCG; R:agctCGGGGAGTGgAtcCACCCCCGG); 1-mt (F:agctGAGgATccGGACCCCCCCTTAA; R:agctTTAAGGGGGGGTCCggATcCTC); +6 (F:atggatccTCCCCGGGGCTGTCC; R:atggatccGTGAAATCACCCCCGGG); +10 (F:atggatccatTCCCCGGGGCTGTCC; R:atggatccatGTGAAATCACCCCCGGG) along with vector-specific primers HindIII (CTCGCCAAGCTTGGAAGAG) for F primer or KpnI (CACACCGGGTACCGTGCAC) for R primer. PCR products were cloned at HindIII/KpnI of pXP-1 vector. All constructs were verified by DNA sequencing.

Nuclear Extracts and Electrophoretic Mobility Shift Assay-- Oligonucleotide probes were radiolabeled with [alpha -32P]dCTP (Amersham Pharmacia Biotech): 1 (F: agctGAGTATGGGGACCCCCCCTTAA; R: agctTTAAGGGGGGGTCCCCATACTC); 2 (F: agctGGGTCTGTGAATTCCCGGGGGT; R: agctACCCCCGGGAATTCACAGACCC); 2a (F: agctTCCCCGGGGCTGTCCCAGGCTT; R: agctAAGCCTGGGACAGCCCCGGGGA); 3 (F: agctGCTCATGGGTTTCTCCACCAAG; R: agctCTTGGTGGAGAAACCCATGAGC); xi  (F: agctCCGGGGGTGATTTCACTCCCCG; R: agctCGGGGAGTGAAATCACCCCCGG); CK-1 (F: agctGTGTGAGGGGTATCCTTGATGC; R: agctGCATCAAGGATACCCCTCACAC); 2 mt (F: agctGGGTCTtTGAATTCCCGGGGGT; R: agctACCCCCGGGAATTCAaAGACCC); 2a mt (F: agctTCCCCGtaGCTGTCCCAGGCTT; R: agctAAGCCTGGGACAGCtaCGGGGA); 3 mt (F: agctGCTCATtaGTTTCTCCACCAAG; R: agctCTTGGTGGAGAAACtaATGAGC); and xi -mt1, xi -mt2, xi -mt3, and 1-mt (as described above). Mono Mac 6 cells (10 × 106 to 20 × 106) were stimulated with 100 ng/ml LPS for 1 h, and nuclear extracts were prepared as described previously (25). The binding reaction contained 12 mM HEPES, pH 7.8, 80-100 mM KCl, 1 mM EDTA, 1 mM EGTA, 12% glycerol, and 0.5 µg of poly(dI-dC) (Amersham Pharmacia Biotech). Nuclear extracts (1-4 µg) or recombinant proteins (10-50 ng) were mixed in an 8-µl reaction with 0.2-0.5 ng of labeled probe (1-5 × 104 cpm) and incubated at room temperature for 10 min. The reaction was analyzed by electrophoresis in a nondenaturing 5% polyacrylamide gel at 4 °C in 0.5× TBE buffer. For supershift analysis, the reaction mixture was preincubated with appropriate antiserum (Santa Cruz) at room temperature for 5-10 min prior to addition of the labeled probe. Indicated gels were quantified using the PhosphorImager (Molecular Dynamics).

UV Cross-linking and Immunoprecipitation-- The binding reaction was performed with radiolabeled oligoduplex corresponding to the site xi  in which three central dT nucleotides were substituted with bromodeoxyuridine. The EMSA gel was UV illuminated at 302 nm for 30 min at 4 °C and exposed to autoradiography for 2-4 h at the same temperature. The region corresponding to the DNA-protein complex was excised, and the proteins were eluted in 2× SDS buffer (100 mM Tris-Cl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 20% glycerol) at 37 °C overnight. They were further processed either for SDS-PAGE or for immunoprecipitation as described (26).

Methylation Interference Analysis-- Oligonucleotide 2-F (or 2a-R) was labeled with [gamma -32P]ATP (Amersham) and used as primer in a PCR along with 2a-R (or 2-F). The PCR fragment obtained (5 × 105 cpm) was gel purified and partially methylated in 200 µl of buffer containing 200 mM HEPES, pH 7.8, 1 mM EDTA by adding 1 µl of dimethyl sulfate at room temperature for 1 min. The reaction was stopped by addition of 40 µl of stop solution (1.5 M sodium acetate, pH 5.2, 1 M beta -mercaptoethanol). DNA was precipitated and washed several times. The conditions of recombinant protein-DNA binding reactions were the same as for EMSA but scaled up 5-10 times. Bound and free DNAs were eluted overnight at 37 °C in 50 mM Tris-Cl, pH 8.0, 1 M NaCl, 2 mM EDTA. The DNA was purified and dissolved in 90 µl of H2O, 10 µl of piperidine was added, and the sample was incubated at 90 °C for 30 min and cooled on dry ice. Traces of piperidine were removed by three cycles of evaporation. Cleaved DNA fragments were separated by electrophoresis using a 13% sequencing gel.

DNase I Footprinting Assay-- Solid phase DNase I footprinting was carried out using the methodology described previously (27). DNA probes were generated by PCR amplification using biotinylated primer TNF-480 (TTGAGTCCTGAGGCCTGTGT) along with [gamma -32P]ATP-labeled primer TNF-680 (GCATTATGAGTCTCCGGGTC) or vice versa. Following gel purification, radiolabeled DNA probe was adsorbed onto magnetic Dynabeads M-280 Streptavidin (Dynal) according to the manufacturer's instructions. 2-4 × 104 cpm of bead-DNA probe was incubated with 5-20 µg of nuclear extracts in 160 µl of binding buffer at room temperature for 20 min. Following addition of 160 µl of salt mixture (10 mM MgCl2, 5 mM CaCl2) 0.06-0.25 units DNase I (Boehringer Mannheim) was added to the mixture and incubated at room temperature for 30 s. An equal volume of STOP solution was added (0.5 M NaCl, 40 mM EDTA, 1% SDS), and digested DNA was recovered using the Magnetic Particle Concentrator (Dynal). DNA was washed with 200 µl of solution I (2 M NaCl, 20 mM EDTA) followed by 200 µl of solution II (10 mM Tris-Cl, pH 8.0, 1 mM EDTA) twice. The reaction was analyzed on 7% sequencing gel. Where indicated autoradiograms were recorded digitally using the UVP Image Store 5000 system (UVP Life Sciences, Cambridge, UK) and analyzed with NIH Image 1.6 software (public domain).

Expression and Purification of Recombinant Proteins-- The protein sequences corresponding to amino acids 2-400 of human p50 and amino acids 2-306 of human p65 were recovered by PCR using the appropriate primers. p50 and p65Delta cDNAs were cloned into the bacterial expression vector pET32a (Novagen) and used to transform BL21(DE3)LysS bacterial strain. Cultures were grown to A600 = 0.4-0.6, induced with 1 mM isopropyl-1-thio-beta -D-galactopyranoside (Sigma), and then grown for an additional 3 h before harvesting. Bacterial pellets were resuspended in buffer A (50 mM Tris-Cl, pH 8.0, 0.1 mM EDTA, 0.01% Nonidet P-40, 1 mM dithiothreitol, 10% glycerol) containing 70 mM NaCl and lysed by three sonication cycles. Insoluble material was removed by centrifugation, and cleared lysate was absorbed to biotin-labeled oligoduplex corresponding to consensus NF-kappa B binding sequence bound to streptavidin-agarose (Sigma) for 30-60 min at room temperature. The agarose beads were washed twice with buffer A containing 100 mM NaCl, and the bound protein was eluted with buffer A containing 500 mM NaCl. To form p65Delta /p50 heterodimer, cleared lysates containing equal amounts of recombinant p50 and p65Delta were mixed and denatured by adding urea to 8 M, followed by step dialysis against buffer A containing 70 mM NaCl and 6, 4, 2, 1, 0.5, or 0 M urea. The heterodimer was purified from total extract as described above. The purity and concentration of recombinant proteins were assessed on SDS-PAGE gel.

Cell Culture, Transfections, and Luciferase Assay-- Mono Mac 6 cells were maintained as described previously (24). Transient transfections were performed on Mono Mac 6 cells by the DEAE-dextran method as described previously (15). Cells were plated in fresh medium at 5 × 105/ml 24 h prior to transfection. The concentration of DEAE-dextran (Amersham Pharmacia Biotech) used was 100 µg/ml. After transfection cells were incubated for 24 h prior to LPS activation (1 µg/ml) and for a further 6-12 h before harvesting. Luciferase assay was performed using the Luciferase assay system and Turner Luminometer model 20 (Promega) according to the protocol supplied.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Functional Characterization of the NF-kappa B-like Sites of the Human TNF Promoter Region in Human Monocytes-- To examine whether LPS-inducible specific DNA-protein complexes can be formed at NF-kappa B-like sites within the human TNF promoter region in human monocytes, oligonucleotide duplexes spanning these sites were tested in EMSA with nuclear extracts from unstimulated and LPS-stimulated Mono Mac 6 cells. LPS stimulation resulted in formation of NF-kappa B/Rel-specific complexes at sites kappa B1, kappa B2, kappa B2a, and kappa B3, although they differed considerably in intensity (Fig. 1). Because no NF-kappa B/Rel-specific complexes were formed at site CK-1 (data not shown), this site was excluded from further analysis. The strongest binding was observed at site kappa B1, which formed two NF-kappa B-specific complexes corresponding to p50/p50 homodimer (I) and p65/p50 heterodimer (II), respectively, as defined by using NF-kappa B/Rel-specific antibodies (data not shown). The binding at the sites kappa B2 and kappa B2a was about three times weaker, and the complex formed at site kappa B3 was at the limit of detection (>10 times weaker than that at site kappa B1).


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 1.   Nuclear factors binding to sites kappa B1, kappa B2, kappa B2a, and kappa B3. Nuclear extracts from Mono Mac 6 cells before and after 1 h of stimulation with LPS were used in EMSA with probes corresponding to kappa B1 (lanes 1 and 2), kappa B2 (lanes 3 and 4), kappa B2a (lanes 5 and 6), or kappa B3 (lanes 7 and 8). Supershift assay (not shown) indicated that complex I consists of p50/p50 homodimer, and complex II consists of p65/p50 heterodimer. Non-NF-kappa B complexes marked as n.

To examine the role of each site in LPS-inducible transcriptional activation, we generated a set of reporter constructs with 1.2 kilobase pairs of TNF promoter sequence placed in front of a luciferase reporter gene. Point mutations were created at each of the NF-kappa B binding sites, using specific mutations that disrupted the formation of NF-kappa B/Rel-specific complexes when tested by EMSA as above (data not shown). When these constructs were expressed in Mono Mac 6 cells, mutation at site kappa B1 had little effect on LPS-inducible luciferase activity, whereas mutation at site kappa B2 or site kappa B2a resulted in a significant decrease of luciferase activity (approximately 50% reduction of the wild type construct), and mutation at site kappa B3 had a lesser effect (15-20%) (Fig. 2). Thus, despite the fact that kappa B1 site appears to have a higher affinity to NF-kappa B/Rel proteins, sites kappa B2 and kappa B2a appear to have a greater effect on transcriptional activation of the TNF gene in Mono Mac 6 cells.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of site-directed mutations in the NF-kappa B-like sites of the human TNF promoter on LPS-inducible transcriptional regulation of the gene. Schematic representation of the human TNF promoter depicting NF-kappa B-like sites. Site-directed mutations were shown by EMSA to abolish NF-kappa B binding to the corresponding site. Results are expressed as percentages (and standard error) of the fold induction of the wild type construct (11.1 ± 0.94, 12 independent experiments in Mono Mac 6 cells). The number of independent experiments for each mutant is indicated near the corresponding bar. kappa B2-mt and kappa B2a-mt gave significantly lower inducibility than wild type (wt) (p < 0.01, by paired two-tailed t test).

Inducible Occupancy of a Cluster of Three Sites in the Distal Part of the Human TNF Promoter Region-- To explore DNA-protein interactions around the kappa B2 and kappa B2a sites, we performed DNase I footprinting analysis of a segment spanning -680 to -480 nt using nuclear extracts prepared from Mono Mac 6 cells before or after LPS stimulation. Nuclear extracts made after LPS stimulation gave protection from DNase I cleavage at sites kappa B2 and kappa B2a and also in the intervening region spanning -616 to -599 nt (Fig. 3A). Nuclear extracts made before LPS stimulation also gave protection in this region when tested at high concentrations. A similar pattern of protection was observed using the noncoding strand (Fig. 3B).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   DNase I footprinting of a probe spanning -680 to -480 nt of the TNF promoter region. G/A ladder prepared by Maxam-Gilbert sequencing of the same fragment. A, coding strand. Titration of amount of nuclear extracts (5, 10, 15, or 20 µg) from unstimulated (lanes 2-5) or LPS-stimulated (lanes 6-9) Mono Mac 6 cells is shown. B, noncoding strand. Naked DNA (lane 2) is compared with DNA incubated with LPS-stimulated (lane 3) Mono Mac 6 cell nuclear extract. C, comparison of coding strand DNA probes bearing specific base substitutions. wt denotes the wild type (lane 3), 2mt is a G to T substitution at -627 nt within the kappa B2 site (lane 4), 2amt is a GG to TA substitution at -597 and -596 nt within the kappa B2a site (lane 5), xi -mt1 is a GTGA to ATCC substitution at -611 to -608 nt in the sequence between sites kappa B2 and kappa B2a (lane 6). D, density analysis of the lanes from panel C. The arrows indicate effects of base substitution, e.g. G to T substitution at -627 nt (2mt) abolishes protection at site kappa B2 but not at kappa B2a or the intervening region.

This observation raised the possibility of a novel binding site between kappa B2 and kappa B2a, but it was also possible that the area of protection in between kappa B2 and kappa B2a might be because of conformational changes brought about by occupancy of the kappa B2 and kappa B2a sites. To examine this question, the above experiments were repeated with DNA bearing specific mutations in kappa B2, kappa B2a, or the intervening sequence. Each mutation was found to cause a site-specific alteration in the DNase I footprint (Fig. 3C). That is, mutation of site kappa B2 abolished the protection of site kappa B2 (but not of kappa B2a or the intervening sequence), whereas mutation of kappa B2a abolished the protection of kappa B2a (but not of kappa B2 or the intervening sequence), and mutation of the intervening sequence abolished the protection of the intervening sequence (but not of kappa B2 or kappa B2a) (Fig. 3D). We therefore proceeded to characterize the putative novel binding site, here termed xi , situated in the 19-nt gap between sites kappa B2 and kappa B2a.

Constitutive and Inducible Binding to the Novel Site, xi -- To examine the binding properties of xi  we used an oligonucleotide duplex matching the sequences from -619 to -597 nt as a probe for EMSA. Nuclear extracts were obtained from Mono Mac 6 cells that had been stimulated with LPS (Fig. 4A). For comparison, the binding complexes observed with probes specific for sites kappa B2 and kappa B2a are shown. Unstimulated nuclear extracts gave a single major complex with the probe for site xi . After stimulation this constitutive complex increased in intensity, and on close inspection, a separate sharp band appeared at its lower margin. The latter inducible complex was at maximal intensity between 15 and 120 min after stimulation (data not shown). These data raised the question of whether the novel site might bind two different factors, one constitutively present and the other rapidly inducible in Mono Mac 6 cells.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 4.   Nuclear factors binding to site xi . A, nuclear extracts from Mono Mac 6 cells before and after 1 h of stimulation with LPS were used in EMSA with probes corresponding to kappa B2 (lanes 1 and 2), kappa B2a (lanes 3 and 4), or the intervening sequence xi  (-619 to -597 nt) (lanes 5 and 6). The xi  probe shows an discrete inducible complex that migrates slightly ahead of the broader constitutive complex (lanes 7 and 8 show longer exposure for lanes 5 and 6). B, effect of specific mutations on protein binding to site xi . Wild type (wt) and different mutant probes (mt1, mt2, and mt3) were incubated with nuclear extracts from unstimulated (lanes 1-4) or stimulated cells (lanes 5-8).

A further EMSA investigated the specificity of these complexes by competition with various unlabeled oligonucleotide duplexes. The constitutive complex was abolished by competition with 100× itself but not by 100× excess of oligoduplexes corresponding to site kappa B2 or kappa B2a (data not shown). In contrast the sharp band of the inducible complex appeared to be inhibited by competition with kappa B2 or kappa B2a at least as effectively as by itself. Competition with unlabeled oligonucleotide duplex corresponding to an EGR-1 binding site had little effect on constitutive or inducible complex formation. These results suggested that constitutive and inducible factors interacting with site xi  are of different origin and that the latter might be related to the NF-kappa B/Rel family.

The distinction between constitutive and inducible binding was also illustrated by the different effects of specific alterations to the xi  sequence (Fig. 4B). A substitution of GTGA right-arrow ATCC at -611 to -608 nt disrupted both constitutive and inducible binding. Interestingly, an ATTT right-arrow GATC substitution at -608 to -605 nt had no effect on inducible binding but abolished constitutive binding. Conversely, these data suggest that a CAC right-arrow GGA substitution at -604 to -602 nt might reduce constitutive binding less completely than inducible binding.

An Inducible Complex Bound to xi  is NF-kappa B (p65/p50) Heterodimer-- The rapid kinetics of the inducible complex suggested the involvement of transcription factor(s) that do not need to be synthesized de novo. Because NF-kappa B provides a classical example of this and because xi  includes a sequence (GTGATTTCAC) that has two mismatches with the consensus NF-kappa B site (GGGPuNNPyCCC, where Pu is purine and Py is pyrimidine), we considered the possibility of an inducible complex being formed by NF-kappa B proteins. Two items of circumstantial evidence are given above. First, the LPS-inducible complex at xi  had similar mobility to the complexes at kappa B2 and kappa B2a, which are known to bind p65/p50 (Fig. 4A). Second, the LPS-inducible complex at xi  was inhibited by competition with the p65/p50 binding sequences of sites kappa B2 and kappa B2a (data not shown). As a more formal test of this question, we performed an EMSA using specific antibodies against two members of the NF-kappa B/Rel family, p65 and p50. Both antibodies markedly diminished the inducible complex, whereas the antibodies against another member of the family, c-Rel, and against transcription factor EGR-1 had no effect on this complex (Fig. 5). Taken together, these results identify a major inducible complex formed at site xi  as p65/p50 NF-kappa B heterodimer.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 5.   Supershift assay using the probe spanning -619 to -597 nt. Nuclear extracts from unstimulated (lane 1) or LPS-stimulated (lanes 2-6) Mono Mac 6 cells in the presence or absence of anti-p50 (lane 3), anti-p65 (lane 4), anti-c-rel (lane 5), or anti-EGR-1 (lane 6) antibodies are shown. ab, antibodies used in supershift assay.

p50 and p65 Exhibit Different Binding Patterns across the kappa B2/xi /kappa B2a Cluster-- Because the various members of the NF-kappa B/Rel family possess different functional properties, we used recombinant forms of p50 and p65 to examine the possibility that each part of the kappa B2/xi /kappa B2a cluster might preferentially recruit a specific type of NF-kappa B complex. The recombinant p65 was truncated at amino acid 306 to facilitate bacterial expression and is denoted p65Delta ; this truncation does not affect the DNA-binding domain.

The results of methylation interference are shown in Fig. 6. It can be seen that p50 homodimers protect site kappa B2a much more strongly than site kappa B2, whereas the opposite is true for p65Delta homodimers. Site xi  is weakly protected by p50 homodimers but poorly protected by p65Delta homodimers. All three sites are protected by p65Delta /p50 heterodimers.


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 6.   Methylation interference footprinting of a probe spanning -633 to -582 nt of the TNF promoter region using recombinant NF-kappa B proteins. G/A ladder prepared by Maxam-Gilbert sequencing of the same fragment. F, free probe; Bp50, Bp65Delta , and Bp65Delta /p50, probes bound to p50/p50 and p65Delta /p65Delta homodimers and p65Delta /p50 heterodimer, respectively.

To provide an indication of relative binding affinity, radiolabeled oligoduplexes corresponding to sites kappa B2, kappa B2a, or xi  were titrated against a standard amount of p50/p50, p65Delta /p65Delta , or p65Delta /p50. DNA-protein complexes were resolved by EMSA and quantitated using a PhosphorImager (Fig. 7A). These data confirm that p50 homodimers bind much more strongly to kappa B2a than to kappa B2 or xi , whereas p65Delta homodimers bind much more strongly to kappa B2 than to kappa B2a or xi . However the binding of p65Delta /p50 heterodimers showed less variation between the three sites, being strongest for kappa B2a and weakest for site xi .


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 7.   Binding affinities of recombinant p50/p50 and p65Delta /p65Delta homodimers and p65Delta /p50 heterodimer to sites kappa B2, kappa B2a, and xi . A, standard amounts of recombinant proteins were incubated with radioactive probes (diluted as described) corresponding to sites kappa B2, kappa B2a, and xi . Lanes 1, 7, and 13, nondiluted probe; lanes 2, 8, and 14, 2 times dilution; lanes 3, 9, and 15, 4 times; lanes 4, 10, and 16, 8 times; lanes 5, 11, and 17, 16 times; lanes 6, 12, and 18, 32 times. Graphs represent quantitative analysis of the autorads. B, EMSA with p65Delta /p50 heterodimer and a probe spanning -633 to -582 nt of the TNF promoter region.

In view of the similar affinity of p65Delta /p50 for each of the three adjacent binding sites, the question arises whether the heterodimer can bind at all three sites simultaneously. When recombinant p65Delta /p50 heterodimer was incubated with an oligoduplex corresponding to the full kappa B2/xi /kappa B2a cluster, EMSA revealed a ladder of three complexes (Fig. 7B) in contrast to the single complexes seen for the individual binding sites. This appearance is consistent with the hypothesis that the cluster is capable of binding one, two, or three heterodimers simultaneously.

All Three Binding Sites Contribute to Inducible Gene Expression in Human Monocytes-- To examine whether binding of protein complexes at the site xi  has any functional effect on transcriptional up-regulation of the TNF gene, we included three different variants of the xi  site whose effects on DNA-protein interactions are illustrated in Fig. 4B, in our set of reporter constructs with 1.2 kilobase pairs of TNF promoter sequence placed in front of a luciferase reporter gene. When expressed in Mono Mac 6 cells variations at the xi  site resulted in a significant decrease of luciferase activity in the range of 40-55% reduction of the wild type (Fig. 8A). When a construct with the point mutations at the sites kappa B2, kappa B2a, and xi  was expressed in Mono Mac 6 cells, LPS-induced activity of the gene-reporter dropped even further and resulted in about 70% reduction of the wild type (Fig. 8A).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of site-directed and phasing mutations at the site xi  on TNF promoter activity in response to LPS. Cluster of elements between -627 nt and -598 nt is depicted. Results are expressed as percentages of the fold induction of the wild type construct. Number of independent experiments for each mutant is indicated near the corresponding bar. A, mutations in corresponding elements are shown. xi -mt1, xi -mt2, xi -mt3, and kappa B2/xi /kappa B2a each gave significantly lower levels of inducibility than wild type (wt, p < 0.01 for each comparison by paired two-tailed t test). B, the position of the 6- or 10-nt insertion is marked. Both 6- and 10-nt insertions gave significantly lower inducibility than wild type (wt, p < 0.01, by paired two-tailed t test).

To explore the effect of proximity of the three sites in transactivation of the TNF gene, we introduced into the full TNF promoter a spacer of 6 or 10 nt between site xi  and site kappa B2a, thereby creating an additional half-turn or full turn of the DNA helix. Both insertions resulted in decrease of luciferase activity by about 30% (Fig. 8B).

Thus, each element of this cluster participates in transcriptional regulation of the TNF gene in human monocytes. Interference with the binding of NF-kappa B/Rel proteins to each site of interaction in the region results in 30% of the original TNF gene expression. Repositioning of the sites causes modest reduction in the level of the gene expression.

Characterization of the Constitutive Complex at xi -- UV cross-linking experiments were carried out to investigate the nature of the factor(s) that bind to xi . Nuclear extracts from unstimulated Mono Mac 6 cells were incubated with a bromodeoxyuridine-substituted oligonucleotide probe, and the complexes were separated by EMSA. After UV cross-linking, the complexes were excised and eluted from the gel. When the purified complexes were analyzed by SDS-PAGE, a major band was seen at Mr ~50 kDa (Fig. 9A). Because the oligoduplex itself migrates at about 10 kDa in this gel system, this would suggest that the constitutive binding factor contains a major component of approximately 40 kDa. UV cross-linking experiments with nuclear extracts from stimulated Mono Mac 6 cells showed the same constitutive component plus two additional bands of ~75 and ~60 kDa consistent with p65 and p50 (Fig. 9, A, lane 2, and B, lane 1). To provide further confirmation that the inducible complexes contain p65/p50 heterodimer, the cross-linked products were immunoprecipitated with monospecific antibodies and then analyzed on SDS-PAGE. Anti-p65 antibodies immunoprecipitated a complex that would correspond to a protein of 65 kDa, whereas anti-p50 antibodies immunoprecipitated a complex corresponding to a protein of 50 kDa, and control experiments with anti-C/EBP antibodies or anti-biotin antibodies did not yield an immunoprecipitated band (Fig. 9B, lanes 2-5). Taken together, these results indicate that site xi  is constitutively occupied by a protein(s) of about 40 kDa and that LPS stimulation causes p65/p50 NF-kappa B heterodimer to bind at the same site.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 9.   UV cross-linked products of a bromodeoxyuridine-substituted probe spanning -619 to -597 nt with nuclear extracts from Mono Mac 6 cells. Complexes were separated by EMSA, subjected to UV illumination, cut from the gel, and analyzed on SDS-PAGE. A, complexes formed with nuclear extracts from unstimulated (lane 1) or LPS-stimulated (lane 2) Mono Mac 6 cells were analyzed on 4-12% MOPS-SDS gel (Novex). The migration of Rainbow full range molecular weight marker (Amersham Pharmacia Biotech) is indicated on the left. B, complexes formed with nuclear extracts of stimulated Mono Mac 6 cells (lane 1), and after these had been immunoprecipitated with anti-p65 (lane 2), anti-p50 (lane 3), anti-C/EBP (lane 4), or anti-biotin (lane 5) antibodies were separated on 10% Tris-glycine-SDS gel. The migration of rainbow molecular weight marker (Amersham Pharmacia Biotech) is indicated on the right. ab, antibody used in immunoprecipitation.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The aim of the present study was to examine the role of NF-kappa B in the regulation of TNF transcription in Mono Mac 6, a cell line chosen because of its close similarity to well differentiated human monocytes (24). When the functional effects of four different NF-kappa B-like sites in the TNF promoter region were compared by point mutagenesis and reporter gene expression, two neighboring sites in the distal part of the promoter region were identified as making the greatest contribution to LPS-induced gene expression. We show that in between these two sites, denoted kappa B2 and kappa B2a, there is a 19-nt sequence that binds both constitutive and inducible nuclear factors. This intervening sequence is referred to here as xi , and the cluster as a whole can be summarized as -627kappa B2/xi /kappa B2a-589, although the functional boundaries of the novel binding sites within xi  remain uncertain.

The capacity of the kappa B2/xi /kappa B2a cluster to bind NF-kappa B has two interesting features. The first is that three NF-kappa B complexes can bind to such a short segment of DNA. Whether they do so simultaneously is a matter for further investigation, but DNase I footprinting patterns suggest that this might be the case. A further suggestion comes from a comparison of the EMSA behavior of the individual binding sites with that of the full kappa B2/xi /kappa B2a region. Whereas the individual binding sites only form one complex when incubated with recombinant p65Delta /p50, the full kappa B2/xi /kappa B2a region forms three separate complexes that would seem to correspond to the binding of one, two, or three heterodimers (Fig. 7B).

The second potentially important aspect is the wide variation in binding affinity across the cluster and the fact that different members of the NF-kappa B/Rel family preferentially bind to different parts of the cluster. Site kappa B2 has relatively high affinity for p65Delta homodimer but relatively weak affinity for p50 homodimer, whereas the opposite is true for site kappa B2a. Such preferential binding patterns are likely to be explained by minor sequence differences between the sites (28), yet it is intriguing that we find little variation in binding affinity for p65/p50, the canonical form of NF-kappa B, between all three sites. As shown in Fig. 7A, the difference in p65/p50 binding affinity between site kappa B2a, which is strongest, and site xi , which is weakest, is in the region of only 3-4-fold. We do not know whether the polarization of the cluster in respect to p65/p65 and p50/p50 binding affinity is of functional significance. But it has been observed that the acquisition of LPS tolerance in Mono Mac 6 cells is associated with a shift in the predominant form of NF-kappa B from p65/p50 heterodimer to p50 homodimer, suggesting that the former activates and the latter tends to suppress TNF expression (29). Thus, it is interesting to speculate that one function of the kappa B2/xi /kappa B2a cluster within human macrophages might be to switch LPS-induced TNF expression on and off by allowing active interaction between different forms of NF-kappa B and the elements of the cluster.

Gene reporter expression was approximately halved by mutations that interfered with NF-kappa B binding to any of the three sites in the kappa B2/xi /kappa B2a region. Artificial spacing introduced between the sites also resulted in reduction of gene expression. These data suggest that each element of the cluster contributes to gene transcription and that the structural unity of this region may be important for the maximal levels of expression. In addition, when NF-kappa B-specific interactions were ablated throughout the kappa B2/xi /kappa B2a region, LPS-induced transcriptional activation was reduced by 70%. Although the present study focuses specifically on the question of TNF regulation in human monocytes, it raises the more general question as to whether p65/p50 in isolation can activate TNF transcription and, if so, to what extent this depends on the kappa B2/xi /kappa B2a region. Using COS-7 cells we find that overexpression of p65/p50 up-regulates luciferase gene expression by 50-fold in the presence of the wild type TNF promoter but by less than 5-fold if the promoter is disabled in the kappa B2/xi /kappa B2a region as depicted in Fig. 8A.3 Taken together with the present findings, this result highlights the need for further work to understand the context-specific factors that may modulate the functional activity of this region of the promoter in the natural context of human monocytes and other relevant cell types.

An important question in resolving the function of the kappa B/xi /kappa B2a cluster is the nature of the constitutive xi -binding factor that is found in nuclear extracts of Mono Mac 6 cells. The UV cross-linking data indicate that the constitutive complex includes a protein(s) of around 40 kDa that can be clearly distinguished from the LPS-inducible NF-kappa B/Rel proteins. Our EMSA analysis of mutations within xi  would suggest that the inducible binding motif overlaps with, but is not identical to, the constitutive binding motif. One possibility is that the constitutive binding factor recognizes a kappa B-like motif. Examples of this phenomenon include NF-GMa, whose recognition sequence is very similar to the NF-kappa B consensus (17), and recombination signal sequence binding protein Jk, which is associated with the kappa B-binding sequence in the interleukin-6 gene promoter (30). However, these are both unlikely candidates for the xi -binding factor, because they tend to migrate much faster than NF-kappa B on EMSA. A second possibility is that the constitutive factor might recognize another motif embedded within the xi  site, and this raises the further intriguing possibility that it may occupy the site simultaneously with NF-kappa B. The general principle of transcription factor cohabitation is illustrated by a site in the human interferon-beta promoter, which simultaneously binds NF-kappa B and the high mobility group protein HMG I(Y). NF-kappa B contacts the outer GC-rich bases in the major groove of the DNA helix, whereas HMG I(Y) binds to the central AT-rich section that is exposed in the minor groove, and both factors must be present to activate transcription (31-33). We have not formally excluded HMG I(Y) as the xi -binding factor, although the DNA sequence of xi  and the size of the proteins visualized by UV cross-linking would argue against this explanation. We are currently attempting to clone the constitutive xi -binding factor; however, it is clear from these observations that whatever its molecular identity, its effects on the functional activity of NF-kappa B will be of considerable interest.

Understanding the role of NF-kappa B in human TNF gene regulation has proven difficult, with studies using different cell types and stimuli reaching opposite conclusions. Such context specificity may be of particular importance if, as has been shown for other cytokine genes, the functional activity of the promoter region under consideration requires individual transcription factors to be assembled into higher order enhancer complexes (32). It has been recently demonstrated that cooperation of the kappa B3 site with an adjacent cAMP-responsive element site provides an enhancement of TNF transcription in LPS-stimulated THP-1 cells (13). Our findings support the notion that an assembly of protein complexes at kappa B2/xi /kappa B2a is required for efficient induction of TNF transcription by LPS in Mono Mac 6 cells. Further studies are needed to understand the functional significance of specific interactions that may occur in this region between each of the NF-kappa B binding sites and between NF-kappa B and other nuclear factors.

    ACKNOWLEDGEMENTS

We thank Dr. H. W. L. Ziegler-Heitbrock (Institute for Immunology, Munich, Germany) for providing us with the Mono Mac 6 cell line and for helpful discussions; Dr. J. Frampton for providing us with pXP-1 plasmid; Dr. M. Shchepinov for assistance with synthesis of modified oligonucleotides; Dr. K. Rockett for help in manuscript preparation (all from Oxford University, Oxford, UK); and Dr. D. Kuprash (Engelhardt Institute of Molecular Biology, Moscow, Russia) for providing us with unpublished results and for valuable comments and advice on the manuscript.

    FOOTNOTES

* This work was supported by the Medical Research Council (UK).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

To whom correspondence should be addressed. Tel.: 44-1-865-222-345; Fax: 44-1-865-222-626; E-mail: iudalova{at}worf.molbiol.ox.ac.uk.

Dagger Dagger International Research Scholar of the Howard Hughes Medical Institute. Supported by Grant 96-04-49491 from the Russian Foundation for Basic Research.

The abbreviations used are: LPS, lipopolysaccharide; TNF, tumor necrosis factor-alpha ; NF-kappa B, nuclear factor kappa B; nt, nucleotide(s); PCR, polymerase chain reaction; EMSA, electrophoretic mobility shift assay; PAGE, polyacrylamide gel electrophoresis; MOPS, 4-morpholinepropanesulfonic acid.

2 D. Kuprash, I. Udalova, and S. A. Nedospasov, manuscript in preparation.

3 I. A. Udalova, J. C. Knight, V. Vidal, S. A. Nedospasov, and D. Kwiatkowski, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Beutler, B., and Cerami, A. (1989) Annu. Rev. Immunol. 7, 625-656[CrossRef][Medline] [Order article via Infotrieve]
  2. Beutler, B., Han, J., Kruys, V., and Giroir, B. P. (1992) in Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine (Beutler, B., ed), pp. 561-574, Raven Press, New York
  3. Jongeneel, C. V. (1992) in Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine (Beutler, B., ed), pp. 539-559, Raven Press, New York
  4. Economou, J. S., Rhoades, K., Essner, R., McBride, W. H., Gasson, J. C., and Morton, D. L. (1989) J. Exp. Med. 170, 321-326[Abstract]
  5. Goldfeld, A. E., Doyle, C., and Maniatis, T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9769-9773[Abstract]
  6. Trede, N. S., Tsytsykova, A. V., Chatila, T., Goldfeld, A. E., and Geha, R. S. (1995) J. Immunol. 155, 902-908[Abstract]
  7. Leitman, D. C., Ribeiro, R. C., Mackow, E. R., Baxter, J. D., and West, B. L. (1991) J. Biol. Chem. 266, 9343-9346[Abstract/Free Full Text]
  8. Rhoades, K. L., Golub, S. H., and Economou, J. S. (1992) J. Biol. Chem. 267, 22102-22107[Abstract/Free Full Text]
  9. Pope, R. M., Leutz, A., and Ness, S. A. (1994) J. Clin. Invest. 94, 1449-1455[Medline] [Order article via Infotrieve]
  10. Kramer, B., Meichle, A., Hensel, G., Charnay, P., and Kronke, M. (1994) Biochim. Biophys. Acta 1219, 413-421[Medline] [Order article via Infotrieve]
  11. Kramer, B., Wiegmann, K., and Kronke, M. (1995) J. Biol. Chem. 270, 6577-6583[Abstract/Free Full Text]
  12. Tsai, E. Y., Jain, J., Pesavento, P. A., Rao, A., and Goldfeld, A. E. (1996) Mol. Cell. Biol. 16, 459-467[Abstract]
  13. Yao, J., Mackman, N., Edington, T. S., and Fan, S.-T. (1997) J. Biol. Chem. 272, 17795-17801[Abstract/Free Full Text]
  14. Collart, M. A., Baeuerle, P., and Vassalli, P. (1990) Mol. Cell. Biol. 10, 1498-1506[Medline] [Order article via Infotrieve]
  15. Shakhov, A., Collart, M., Vassalli, P., Nedospasov, S., and Jongeneel, C. (1990) J. Exp. Med. 171, 35-47[Abstract]
  16. Kuprash, D. V., Udalova, I. A., Turetskaya, R. L., Rice, N. R., and Nedospasov, S. A. (1995) Oncogene 11, 97-106[Medline] [Order article via Infotrieve]
  17. Shannon, M. F., Pell, L. M., Lenardo, M. J., Kuczek, E. S., Occhiodoro, F. S., Dunn, S. M., and Vadas, M. A. (1990) Mol. Cell. Biol. 10, 2950-2959[Medline] [Order article via Infotrieve]
  18. Shakhov, A. N., Kuprash, D. V., Azizov, M. M., Jongeneel, C. V., and Nedospasov, S. A. (1990) Gene (Amst.) 95, 215-222[Medline] [Order article via Infotrieve]
  19. Haas, J. G., Baeuerle, P. A., Riethmuller, G., and Ziegler-Heitbrock, H. W. L. (1990) Proc. Natl Acad. Sci. U. S. A. 87, 9563-9567[Abstract]
  20. Ziegler-Heitbrock, H. W. L., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Baeuerle, P., and Strobel, M. (1993) J. Immunol. 151, 6986-6993[Abstract/Free Full Text]
  21. Hensel, G., Meichle, A., Pfizenmaier, K., and Kronke, M. (1989) Lymphokine Res. 8, 347-351[Medline] [Order article via Infotrieve]
  22. Udalova, I. A., Turetskaya, R. L., Kuprash, D. V., and Nedospasov, S. A. (1995) Dokl. Acad. Nauk. (Proc. Russ. Acad. Sci.) 342, 413-417
  23. Stuber, F., Udalova, I. A., Book, M., Drutskaya, L. N., Kuprash, D. V., Turetskaya, R. L., Schade, F. U., and Nedospasov, S. A. (1996) J. Inflamm. 46, 42-50
  24. Ziegler-Heitbrock, H. W. L., Thiel, E., Futterer, A., Herzog, V., Wirtz, A., and Riethmuller, G. (1988) Int. J. Cancer 41, 456-461[Medline] [Order article via Infotrieve]
  25. Schreiber, E., Matthias, P., and Schaffner, W. (1989) Nucleic Acids Res. 17, 6419[Medline] [Order article via Infotrieve]
  26. Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P., and Blasi, F. (1992) EMBO J. 11, 205-213[Abstract]
  27. Sandaltzopoulos, R., and Becker, P. B. (1994) Nucleic Acids Res. 22, 1511-1515[Medline] [Order article via Infotrieve]
  28. Kunsch, C., Ruben, S., and Rosen, C. A. (1992) Mol. Cell. Biol. 12, 4412-4421[Abstract]
  29. Ziegler-Heitbrock, H. W. L., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P., Sternsdorf, T., Baeuerle, P. A., Haas, J. G., and Reithmuller, G. (1994) J. Biol. Chem. 269, 17001-17004[Abstract/Free Full Text]
  30. Plaisance, S., Berghe, W. V., Boone, E., Fiers, W., and Haegeman, G. (1997) Mol. Cell. Biol. 17, 3733-3743[Abstract]
  31. Lehming, N., Thanos, D., Brinkman, J. M., Ma, J., Maniatis, T., and Ptashne, M. (1994) Nature 371, 175-179[CrossRef][Medline] [Order article via Infotrieve]
  32. Thanos, D., and Maniatis, T. (1995) Cell 83, 1091-1100[Medline] [Order article via Infotrieve]
  33. Thanos, D., and Maniatis, T. (1992) Cell 71, 777-789[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.